US: Dow-DuPont merger subject of September hearing by Senate Judiciary Committee
The merger between The Dow Chemical and DuPont is the topic of a hearing in September requested by one concerned US senator.
US Sen. Chuck Grassley, R-Iowa, serves as the chairman of the Senate’s Judiciary Committee and recently called for a hearing on the merger, and its effect on the seed and chemical industry. Details were not finalized for the hearing, set for late September, and it is unclear who will represent the two chemical companies at the hearing.
According to a statement on Grassley’s website, the hearing will “focus on the transactions currently being reviewed by antitrust regulators, and the current trend in consolidation of the seed and chemical industries.”
“The seed and chemical industries are critical to agriculture and the nation’s economy, and Iowans are concerned that this sudden consolidation in the industry could cause rising input costs in an already declining agriculture economy,” Grassley said in a statement.
The $130 billion “merger of equals,” as it has been dubbed, would result in a combined company to be known as DowDuPont. It would then spin off into three independent, publicly traded companies within 18 to 24 months after the merger is closed, and is subject to regulatory and board approval.
In addition to the Senate Judiciary Committee, the merger is being scrutinized by the Department of Justice and the European Union.
Full Content: Midland Daily News
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
UK Probes Lindab’s Acquisition of HAS-Vent Amid Fears of Market Monopoly
Apr 28, 2024 by
CPI
Shein Faces EU Regulations Over User Data
Apr 28, 2024 by
CPI
Google Fights Back Against US Antitrust Lawsuit
Apr 28, 2024 by
CPI
US Homeland Security Establishes Blue-Ribbon Board with Tech CEOs to Advise on AI
Apr 28, 2024 by
CPI
FTC Accuses Amazon Executives of Using Disappearing Messaging Apps to Conceal Evidence
Apr 28, 2024 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Economics of Criminal Antitrust
Apr 19, 2024 by
CPI
Navigating Economic Expert Work in Criminal Antitrust Litigation
Apr 19, 2024 by
CPI
The Increased Importance of Economics in Cartel Cases
Apr 19, 2024 by
CPI
A Law and Economics Analysis of the Antitrust Treatment of Physician Collective Price Agreements
Apr 19, 2024 by
CPI
Information Exchange In Criminal Antitrust Cases: How Economic Testimony Can Tip The Scales
Apr 19, 2024 by
CPI